A major advance in cancer research is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial malignant suppressor protein is frequently disabled in various kinds of tumors, leading https://thekiwisocial.com/story7565291/vhh-fragments-reactivate-the-p53-protein-the-promising-pathway-for-malignant-management